Sign In
Buy INCY
$97.98
+5.74 (+6.22%)
At Close: Jun 03, 2026
16,196 Shares in Incyte Corporation $INCY Bought by Azzad Asset Management Inc. ADV
03:06am, Monday, 09'th Feb 2026
Azzad Asset Management Inc. ADV bought a new position in shares of Incyte Corporation (NASDAQ: INCY) during the undefined quarter, according to its most recent Form 13F filing with the Securities and
Candriam S.C.A. Lowers Stock Holdings in Incyte Corporation $INCY
03:06am, Monday, 09'th Feb 2026
Candriam S.C.A. lowered its stake in Incyte Corporation (NASDAQ: INCY) by 26.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund
Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards?
09:25am, Friday, 06'th Feb 2026
INCY heads into Q4 earnings with strong Jakafi sales, rising royalties and multiple new launches contributing to revenues, setting the stage for a potential upside surprise.
Unveiling Incyte (INCY) Q4 Outlook: Wall Street Estimates for Key Metrics
10:16am, Thursday, 05'th Feb 2026
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Incyte (INCY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quar
Pre-Market Stock Futures: Futures are trading lower once again after another up-and-down day on Wall Street. Once again, the rotation narrative rang out as software and chip stocks were hit hard, and
4,901 Shares in Incyte Corporation $INCY Acquired by Optimize Financial Inc
04:34am, Thursday, 05'th Feb 2026
Optimize Financial Inc bought a new stake in Incyte Corporation (NASDAQ: INCY) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commiss
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Wednesday, 04'th Feb 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth
11:01am, Tuesday, 03'rd Feb 2026
Incyte (INCY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Tuesday, 03'rd Feb 2026
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Mirae Asset Global Investments Co. Ltd. Increases Stake in Incyte Corporation $INCY
04:46am, Tuesday, 03'rd Feb 2026
Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Incyte Corporation (NASDAQ: INCY) by 28.2% during the third quarter, according to the company in its most recent filing with t
Convergence Investment Partners LLC Grows Position in Incyte Corporation $INCY
03:14am, Tuesday, 03'rd Feb 2026
Convergence Investment Partners LLC raised its holdings in Incyte Corporation (NASDAQ: INCY) by 246.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The fi
MORGES, Switzerland--(BUSINESS WIRE)---- $INCY--Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC).
Hussman Strategic Advisors Inc. Has $2.67 Million Stock Position in Incyte Corporation $INCY
05:52am, Wednesday, 28'th Jan 2026
Hussman Strategic Advisors Inc. reduced its position in shares of Incyte Corporation (NASDAQ: INCY) by 50.0% in the undefined quarter, according to its most recent filing with the Securities and Excha
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results
08:00am, Tuesday, 27'th Jan 2026
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2025 financial results conference call and webcast for 8:00 a.m. ET on Tue
Here's Why Incyte (INCY) is a Strong Momentum Stock
10:51am, Monday, 26'th Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
